Secukinumab provided significant and sustained improvement in the signs and symptoms of ankylosing spondylitis: results from the 52-week, Phase III China-centric study, MEASURE 5-Reference-Cited by-同舟云学术

Secukinumab provided significant and sustained improvement in the signs and symptoms of ankylosing spondylitis: results from the 52-week, Phase III China-centric study, MEASURE 5

Published:2020-09-10 Issue:21 Volume:133 Page:2521-2531
ISSN:0366-6999
Container-title:Chinese Medical Journal
language:en
Short-container-title:

Author:

Huang Feng,Sun Fei,Wan Wei-Guo,Wu Li-Jun,Dong Ling-Li,Zhang Xiao,Kim Tae-Hwan,Sengupta Raj,Šenolt Ladislav,Wang Yi,Qiu Hao-Min,Porter Brian,Haemmerle Sibylle

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,General Medicine

Reference29 articles.

1. Ankylosing spondylitis;Braun;Lancet,2007

2. Quality of life and related variables in patients with ankylosing spondylitis;Bodur;Qual Life Res,2011

3. Update on ankylosing spondylitis: current concepts in pathogenesis;Smith;Curr Allergy Asthma Rep,2015

4. Global prevalence of ankylosing spondylitis;Dean;Rheumatology (Oxford),2014

5. Rheumatic diseases in China;Zeng;Arthritis Res Ther,2008

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-17 inhibitors in axial spondyloarthritis. An overview;Expert Opinion on Biological Therapy;2024-08-21

2. A secukinumab dose-escalation study in patients with ankylosing spondylitis not achieving inactive disease after 16 weeks of treatment;Rheumatology;2024-08-12

3. Matching-Adjusted Indirect Comparison of the 52-Week Efficacy of Bimekizumab Versus Secukinumab and Ixekizumab for the Treatment of Radiographic Axial Spondyloarthritis;Rheumatology and Therapy;2024-06-25

4. Risk of infections in psoriatic arthritis or axial spondyloarthritis patients treated with targeted therapies: A meta-analysis of randomized controlled trials;Joint Bone Spine;2024-05

5. Effect of Secukinumab Versus Adalimumab Biosimilar on Radiographic Progression in Patients With Radiographic Axial Spondyloarthritis: Results From a Head‐to‐Head Randomized Phase IIIb Study;Arthritis & Rheumatology;2024-04-30